![Pablo Umaña](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Pablo Umaña is the founder of Roche Glycart AG, which was founded in 2000.
He held the title of Research Director at the time of founding.
Additionally, he worked as Head-Cancer Immunotherapy Discovery at Roche Holding AG in a former position.
Pablo Umaña active positions
| Companies | Position | Start |
|---|---|---|
Roche Glycart AG
 Roche Glycart AG Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that engages in research, development and commercialization of antibody-based products | Founder | 2000-08-31 |
Former positions of Pablo Umaña
| Companies | Position | End |
|---|---|---|
| ROCHE HOLDING AG | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
3
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Roche Glycart AG
Roche Glycart AG Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that engages in research, development and commercialization of antibody-based products | Health Technology |
- Stock Market
- Insiders
- Pablo Umaña
